Reckitt Benckiser Group’s (RB) Buy Rating Reiterated at Liberum Capital

Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reaffirmed by analysts at Liberum Capital in a research report issued to clients and investors on Monday. They presently have a GBX 8,000 ($108.49) price objective on the stock. Liberum Capital’s target price points to a potential upside of 17.87% from the stock’s previous close.

A number of other brokerages also recently issued reports on RB. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a GBX 7,500 ($101.71) price objective on shares of Reckitt Benckiser Group in a research report on Tuesday, December 5th. Whitman Howard reaffirmed a “buy” rating and issued a GBX 9,000 ($122.05) price objective on shares of Reckitt Benckiser Group in a research report on Monday, October 16th. Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 7,700 ($104.42) price objective on shares of Reckitt Benckiser Group in a research report on Friday, October 13th. Morgan Stanley set a £100 ($135.61) target price on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Wednesday, October 11th. Finally, Deutsche Bank reissued a “buy” rating and set a GBX 8,500 ($115.27) target price on shares of Reckitt Benckiser Group in a research report on Thursday, October 12th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of GBX 7,591.36 ($102.95).

Shares of Reckitt Benckiser Group (LON RB) traded up GBX 60 ($0.81) during trading on Monday, hitting GBX 6,787 ($92.04). 1,171,948 shares of the stock were exchanged, compared to its average volume of 1,060,000. Reckitt Benckiser Group has a 52-week low of GBX 6,299 ($85.42) and a 52-week high of GBX 8,110.43 ($109.99). The stock has a market cap of $47,770.00 and a P/E ratio of 2,269.90.

In related news, insider Christopher Sinclair bought 2,800 shares of the stock in a transaction on Wednesday, November 1st. The stock was bought at an average price of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34). Also, insider Adrian Nevil Hennah bought 2,285 shares of the stock in a transaction on Wednesday, November 8th. The shares were bought at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29).

ILLEGAL ACTIVITY NOTICE: “Reckitt Benckiser Group’s (RB) Buy Rating Reiterated at Liberum Capital” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/01/29/reckitt-benckiser-groups-rb-buy-rating-reiterated-at-liberum-capital.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply